Avaleht › Atoopiline dermatiit (ekseem) › Florida
Atoopiline dermatiit (ekseem) kliinilised uuringud osariigis Florida
18 uuringut haiguse Atoopiline dermatiit (ekseem) jaoks otsivad osalejaid osariigis Florida.
Linnad osariigis Florida
- Miami9 uuringut
- Tampa7 uuringut
- St. Petersburg5 uuringut
- Miami Gardens4 uuringut
- Coral Springs4 uuringut
- Kendall3 uuringut
- Boca Raton3 uuringut
- Hollywood3 uuringut
- Jacksonville3 uuringut
Ametlik uuringutekst (inglise keeles)
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 110, Miami
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–65 · Kõik sood · Uuendatud 29. sept 2026 · NCT07453602This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- St. Jude Clinical Research- Site Number : 8400049, Doral
- Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Miami
- Novartis Investigative Site, St. Petersburg
VärbamineFaas 2
Vanused 18–100 · Kõik sood · Uuendatud 28. sept 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Fort Lauderdale
- Enveda Investigative Site, Miami
- Enveda Investigative Site, Miramar
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT07298395A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Solutions Through Advanced Research, Jacksonville
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 25. sept 2026 · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Gsi Clinical Research, Margate
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 25. sept 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Coral Gables
- Investigational Site, Jacksonville
- Investigational Site, Margate
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT07003425A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- Olympian Clinical Research, Tampa
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT07223697A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
VärbamineFaas 3
Vanused 12 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ABMED Clinical Research Corp., Cape Coral
- Skin Care Research, Hollywood
- Quality Care Clinical Research, Miami
- ja veel 4
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 28. aug 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
VärbamineFaas 2
Vanused 18–74 · Kõik sood · Uuendatud 12. aug 2026 · NCT07037901A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Boca Raton
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 6. aug 2026 · NCT07643766A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Pediatric Skin Research - Coral Gables /ID# 266308, Coral Gables
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 6. aug 2026 · NCT06461897FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Miami Dermatology and Laser Research, Miami
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–70 · Kõik sood · Uuendatud 22. juuli 2026 · NCT06564389A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Jacksonville
- Leo Pharma Investigational site, Miami
- Leo Pharma Investigational site, Tampa
VärbamineFaas 3
6 Months – 11 Years · Kõik sood · Uuendatud 7. juuli 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Skin Care Research Boca Raton /ID# 263733, Boca Raton
- TrueBlue Clinical Research - Brandon /ID# 265037, Brandon
- Life Clinical Trials - Coral Springs /ID# 267195, Coral Springs
- ja veel 13
VärbamineFaas 3
Vanused 18–63 · Kõik sood · Uuendatud 6. juuli 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Revival Research, Doral
- Floridian Research Institute Llc, Miami
- Global Health Research Center, Inc., Miami Lakes
- ja veel 4
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. mai 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 8597, Boca Raton
- Galderma Investigational Site 7087, Coral Gables
- Galderma Investigational Site 7063, Cutler Bay
- ja veel 7
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 13. märts 2026 · NCT06988605Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.